A Greek Conversational Agent for Hematologic Malignancies: Usability and User Experience Assessment
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a Greek-language conversational agent using AI to collect health data from patients with hematologic malignancies. Early results show the tool is usable and may improve patient engagement in healthcare.
Area Of Science
- Medical Informatics
- Artificial Intelligence in Healthcare
- Patient-Reported Outcomes
Background
- Active patient documentation enhances understanding of therapy efficacy, disease progression, and quality of life in chronic conditions like hematologic malignancies.
- Artificial intelligence (AI), including natural language processing (NLP) and speech recognition, has enabled new healthcare tools.
- Existing tools often lack language-specific adaptations for diverse patient populations.
Purpose Of The Study
- To introduce an innovative, Greek-language conversational agent designed for patients with hematologic malignancies.
- To utilize AI, specifically sentiment analysis, for collecting detailed family histories and symptom data.
- To assess the feasibility and user experience of this novel healthcare tool.
Main Methods
- Development of a conversational agent with NLP and sentiment analysis capabilities.
- Tailoring the agent for the Greek language and specific needs of hematologic malignancy patients.
- Conducting a feasibility study to evaluate the tool's effectiveness and user reception.
Main Results
- The conversational agent successfully incorporates sentiment analysis for data collection.
- Preliminary feasibility study findings indicate positive user experience and usability.
- The tool demonstrates potential for enhanced patient engagement in clinical settings.
Conclusions
- The Greek-language conversational agent is a promising tool for collecting patient-reported data in hematologic malignancies.
- AI-driven conversational agents can improve the efficiency and depth of patient data gathering.
- Further research should explore the long-term impact on patient outcomes and clinical decision-making.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
